NeoPharm CO. LTD (092730) — Long-term Investment Intensity
NeoPharm CO. LTD (092730) has a Long-term Investment Intensity of 1.3% as of December 2019. Long-term investments of ₩1.65 Billion represent 1.3% of total assets of ₩122.74 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are NeoPharm CO. LTD's assets to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
NeoPharm CO. LTD Long-term Investment Intensity (2012–2019)
This chart shows how NeoPharm CO. LTD's Long-term Investment Intensity has evolved across 6 annual periods from 2012 to 2019. As of December 2019, the intensity stands at 1.3%, reflecting long-term investments of ₩1.65 Billion against total assets of ₩122.74 Billion KRW. For the complete balance sheet picture, see 092730 asset base.
Annual Long-term Investment Intensity for NeoPharm CO. LTD (2012–2019)
The table below presents the year-by-year Long-term Investment Intensity for NeoPharm CO. LTD from 2012 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of NeoPharm CO. LTD for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.3% | ₩1.65 Billion | ₩122.74 Billion | ▼ -0.9 pp |
| 2018 | 2.3% | ₩1.66 Billion | ₩72.93 Billion | ▼ -0.5 pp |
| 2017 | 2.8% | ₩1.59 Billion | ₩56.69 Billion | ▼ -1.5 pp |
| 2016 | 4.3% | ₩1.98 Billion | ₩46.51 Billion | ▼ -12.2 pp |
| 2015 | 16.5% | ₩6.65 Billion | ₩40.41 Billion | ▲ +11.8 pp |
| 2012 | 4.7% | ₩1.59 Billion | ₩34.14 Billion | — |